Leiden University Medical Center
Leiden, Zuid-Holland, Netherlands
Purpose
to evaluate the safety and immunogenicity of a full or fractional booster (3rd) dose of a COVID-19 mRNA vaccine in study participants previously vaccinated with either 2 fractional doses or 2 full doses of COVID-19 mRNA vaccines
Division
Global Health
Date
March 2022
Region Served
GLOBAL
Committed amount
$300,000
Grant topic
Pneumonia & Pandemic Preparedness
Duration (months)
17
Grantee location
Leiden, Zuid-Holland, Netherlands
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.